日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13
Share
Share - WeChat

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 日本毛片在线 | 日日摸日日干 | www.99re7| 日韩精品影视 | 神马久久久久久久久 | 国产一级做a爰片在线看免费 | 国产中出 | 在线观看av一区二区 | 天堂中文字幕在线观看 | 丰满少妇乱子伦精品看片 | 三区在线观看 | 欧美专区亚洲专区 | 黄色中文视频 | 中文字幕成人在线观看 | 人人爽视频 | 毛片毛片毛片毛片毛片毛片毛片 | 国产精品欧美亚洲 | 色无极亚洲影院 | 另类ts人妖一区二区三区 | 免费的av片 | 亚洲另类视频 | 国产69久久精品成人看 | 国产又粗又黄的视频 | 亚洲国产高清在线 | 亚洲欧美成人综合 | 久久精品在线观看 | 欧美aⅴ视频| 91成年视频| 网站av在线 | 成人激情综合 | 国产精品一区二区在线观看 | 成年人视频网址 | 黄频网站在线观看 | 天天做夜夜操 | 国产一区欧美 | 五月婷婷在线观看视频 | 精品无人国产偷自产在线 | av在线免费播放网址 | 欧美精品久久久久久久久老牛影院 | 日本国产高清 | 久久国产免费观看 |